Clinical Trial Update: Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts [Phase 3]

View source ↗

Summary

Phase 3 trial assessing pasireotide with aspiration sclerotherapy to enhance hepatic cyst volume reduction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cyst

Drugs mentioned

• Pasireotide (pasireotide)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Symptomatic Dominant Liver Cyst | Phase 3 | Status: COMPLETED